Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery

[Image: see text] Tuberculosis (TB) is the leading cause of mortality globally resulting from an infectious disease, killing almost 1.6 million people annually and accounting for approximately 30% of deaths attributed to antimicrobial resistance (AMR). This despite the widespread administration of a...

Descripción completa

Detalles Bibliográficos
Autores principales: de Wet, Timothy J., Warner, Digby F., Mizrahi, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704484/
https://www.ncbi.nlm.nih.gov/pubmed/31361123
http://dx.doi.org/10.1021/acs.accounts.9b00275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704484/
https://www.ncbi.nlm.nih.gov/pubmed/31361123
http://dx.doi.org/10.1021/acs.accounts.9b00275

Ejemplares similares